Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: A survey among European neurologists

European Journal of Neurology

Volumn 14, Issue 6, 2007, Pages 644-649

  Lledo A ^a   Dellva, M A ^a   Strombom, I M ^a   Wilkie, J L ^a   Jungemann, Mark E ^a   Royer, M G ^b   Simmons, V E ^a   Cavazzoni, P A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Eli Lilly and Company ^*

Author keywords

Adverse effects; Change in physician practice patterns; Drug labeling change; Parkinson's disease; Pergolide; Risk minimization plan; Survey

Indexed keywords

PERGOLIDE;

ADULT; ARTICLE; AWARENESS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG INFORMATION; DRUG LABELING; ELECTROCARDIOGRAM; EUROPE; HUMAN; PARKINSON DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; RISK REDUCTION; VALVULAR HEART DISEASE;

ANTIPARKINSON AGENTS; AWARENESS; DATA COLLECTION; EUROPE; FEMALE; HEART VALVE DISEASES; HUMANS; INTERNATIONAL COOPERATION; MALE; NEUROLOGY; PERGOLIDE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 34249815519     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01801.x     Document Type: Article

References (19)

1. Perachon S, Schwartz JC, Sokoloff P. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. European Journal of Pharmacology 1999 366 : 293 300.
2. Thalamas C, Rajman I, Kulisevski J, et al. Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson's disease. Clinical Neuropharmacology 2005 28 : 120 125.
3. Barone P, Bravi D, Bermejo-Pareja F, et al. Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Neurology 1999 53 : 573 579.
4. Oertel WH, Wolters E, Sampaio C, et al. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: the PELMOPET study. Movement Disorders 2006 21 : 343 353.
5. Olanow CW, Fahn S, Muenter M, et al. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders 1994 9 : 40 47.
6. Baseman DG, O'Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB, Jr. Pergolide use in Parkinson disease is associated with cardiac valve regurgitation. Neurology 2004 63 : 301 304.
7. Van Camp G, Flamez A, Cosyns B, et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 2004 363 : 1179 1183.
8. Pinero A, Marcos-Alberca P, Fortes J. Cabergoline-related severe restrictive mitral regurgitation. New England Journal of Medicine 2005 353 : 1976 1977.
9. Peralta C, Wolf E, Alber H, et al. Valvular heart disease in Parkinson's disease vs. controls: an echocardiographic study. Movement Disorders 2006, 21 : 1109 1113.
10. Van Camp G, Flamez A, Cosyns B, Goldstein J, Perdaens C, Schoors D. Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide. Neurology 2003, 61 : 859 861.
11. Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE. Valvular heart disease in patients taking pergolide. Mayo Clinic Proceedings 2002 77 : 1280 1286.
12. Kim JY, Chung EJ, Park SW, Lee WY. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Movement Disorders 2006 21 : 1261 1264.
13. Waller EA, Kaplan J, Heckman MG. Valvular heart disease in patients taking pergolide. Mayo Clinic Proceedings 2005 80 : 1016 1020.
14. Toole JF. Report of the president. World Neurology 2001 16 : 6. Available at: http://www.wfneurology.org/docs/pdf/WN_mar2001.pdf (accessed 06/20/2006)
15. Association of British Neurologists Working Party on Care of Acute Neurological Emergencies. Acute Neurological Emergencies in Adults. London : Association of British Neurologists, 2002. Available at: http://www.theabn.org/ downloads/AcuteNeurology.pdf (accessed 06/20/2006)
16. Ärztinnen/Ärzte nach Bezeichnungen und ärztlichen Tätigkeitsbereichen. Stand 31.12.2004. In : Tätigkeitsbericht 2004 der Bundesärztekammer. Köln : Deutscher Ärzte-Verlag, page 500 ff. Available at http://www.bundesaerztekammer.de/30/Aerztestatistik/ 03Statistik2004/00Statistik/Tabelle03 (accessed 09/09/2006).
17. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Canadian Medical Association Journal 1997 157 : 408 416.
18. Sbarbaro JA. Can we influence prescribing patterns? Clinical Infectious Diseases 2001 33 (Suppl. 3 S240 244.
19. Pendleton D, Wakeford R. Studying medical opinion: a comparison of telephone interviews and postal questionnaires to general practitioners. Community Medicine 1987 9 : 25 34.